REGENERON VENTURES
Live / Applied — Second extension granted (statement of use) (as of 24 Oct 2025)
What this means for you
Not registered yet, but its 20 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98412120
- Mark type
- Stylized text
- Filed
- 20 Feb 2024
- Published for opposition
- 22 Oct 2024
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 036 — Insurance and financial services: Capital investment; Investment management; Equity capital investment; Providing venture capital, development capital, private equity and investment funding; Financial investment in the field of biotechnology startups; Venture capital funding services to emerging and start-up companies; Venture capital financing.
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 03 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 25 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2025 — SOU EXTENSION 2 GRANTED
- 24 Oct 2025 — SOU EXTENSION 2 FILED
- 24 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 08 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Apr 2025 — SOU EXTENSION 1 GRANTED
- 29 Apr 2025 — SOU EXTENSION 1 FILED
- 29 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED